Shandong Realcan Pharmaceutical Co Ltd (002589) — Cash Flow Reinvestment Rate
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Cash Flow Reinvestment Rate of 2.30x as of June 2025, reinvesting CN¥57.23 Million (capex CN¥52.73 Million plus investments CN¥4.50 Million) from operating cash flow of CN¥24.86 Million. See Shandong Realcan Pharmaceutical Co Ltd (002589) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Realcan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Shandong Realcan Pharmaceutical Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 002589 operating cash flow.
Annual Cash Flow Reinvestment Rate for Shandong Realcan Pharmaceutical Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Shandong Realcan Pharmaceutical Co Ltd. See 002589 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 10.63x | CN¥146.22 Million | CN¥13.76 Million | CN¥26.82 Million | ▲ +743.4% |
| 2024 | 1.26x | CN¥202.17 Million | CN¥160.44 Million | CN¥111.53 Million | ▼ -82.2% |
| 2023 | 7.08x | CN¥584.06 Million | CN¥82.47 Million | CN¥298.38 Million | ▲ +733.8% |
| 2022 | 0.85x | CN¥444.29 Million | CN¥523.07 Million | CN¥170.96 Million | ▼ -26.2% |
| 2021 | 1.15x | CN¥509.85 Million | CN¥442.95 Million | CN¥461.09 Million | ▼ -52.1% |
| 2020 | 2.40x | CN¥996.93 Million | CN¥414.96 Million | CN¥505.39 Million | ▲ +323.2% |
| 2019 | 0.57x | CN¥1.19 Billion | CN¥2.09 Billion | CN¥934.87 Million | ▲ +6.2% |
| 2010 | 0.53x | CN¥37.72 Million | CN¥70.56 Million | CN¥37.72 Million | ▲ +70.6% |
| 2009 | 0.31x | CN¥19.23 Million | CN¥61.38 Million | CN¥19.23 Million | — |